On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
44° Feels Like: 42°
Wind: WSW 5 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Mostly Clear 39°

Tomorrow

Partly Cloudy 68°

Wed Night

Partly Cloudy 43°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Novartis to submit more on heart failure drug after EU setback

The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel October 22, 2013. REUTERS/Arnd Wiegmann
The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel October 22, 2013. REUTERS/Arnd Wiegmann

ZURICH (Reuters) - Novartis said it would ask the European health regulator to look at its heart failure drug serelaxin again after the body took an unfavorable position on it Friday.

"Novartis announced today it will shortly submit a revised filing package, including new data analyses, for re-examination for conditional approval of RLX030, or serelaxin," the Basel-based drugmaker said in a statement.

Novartis, which had originally hoped to win approval for serelaxin this year, said a revised opinion could be granted in the second quarter.

(Reporting By Katharina Bart)

Comments